Previous 10 | Next 10 |
home / stock / xvipf / xvipf news
GOTHENBURG, SE / ACCESSWIRE / July 12, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) PrimECC is a solution used to prime the heart-lung machine before heart-surgery. It is a CE-marked and patent-protected product and is developed to reduce postoperative complications. In 2020 a study ...
GOTHENBURG, SE / ACCESSWIRE / July 10, 2023 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV) A strategic collaboration agreement has been signed between XVIVO and MTJ Aviation, an American medical flight services company. The agreement comes as a positive development following the decision ...
GOTHENBURG, SE / ACCESSWIRE / June 21, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO acquired STAR Teams, an organ recovery service in the US, in November 2021. To meet the rapidly growing demand for recovery services in the US and in order to strengthen the organization's opera...
GOTHENBURG, SE / ACCESSWIRE / May 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) XVIVO's innovative heart technology is currently under investigation in a randomized controlled clinical trial across 15 leading transplant centers in 8 European countries. 202 patients have gone throu...
GOTHENBURG, SE / ACCESSWIRE / May 11, 2023 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL) (FRA:3XV) The Board of Directors of XVIVO Perfusion AB (publ) (" XVIVO ") has, based on the authorisation given by the Annual General Meeting held on 25April 2023, resolved on a new issue of 67,551 shares. Th...
GOTHENBURG, SE / ACCESSWIRE / April 25, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) The following resolutions were passed at the Annual General Meeting (the "AGM") of XVIVO Perfusion AB (publ) ("XVIVO Perfusion" or the "Company") held today on 25 April 2023 in Gothenburg, Sweden. ...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Record quarter for sales and gross margin First quarter 2023 (Jan 1 - Mar 31) • Net sales amounted to SEK 140.6 million (92.7), corresponding to an increase of 52 percent in SEK and 39 ...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 17, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Invitation to attend XVIVO's conference call regarding the presentation of the interim report January-March 2023. The presentation will be held in English. Time: Monday, April 24 at 2.00 p.m. CE...
GOTHENBURG, SE / ACCESSWIRE / April 3, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today XVIVO Perfusion AB (publ) publish the Annual Report for 2022. The Annual Report is attached to this press release in pdf format and in ESEF format (European Single Electronic Format) and is al...
GOTHENBURG, SE / ACCESSWIRE / March 23, 2023 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL) (FRA:3XV) XVIVO Perfusion AB (publ) (the "Company"), reg. no. 556561-0424, with its registered office in Gothenburg, gives notice of the the Annual General Meeting to be held on Tuesday 25 April 2023 at 3:00 ...
News, Short Squeeze, Breakout and More Instantly...
Xvivo Perfusion Ab Ord Company Name:
XVIPF Stock Symbol:
OTCMKTS Market:
GOTHENBURG, SWEDEN / ACCESSWIRE / April 24, 2024 / XVIVO Perfusion AB (STO:XVIVO) (LSE:0RKL)(FRA:3XV) First quarter 2024 (Jan 1 - Mar 31) • Net sales amounted to SEK 186.0 million (140.6), corresponding to an increase of 32 percent in SEK and equivalent increase, 32 percent, adjusted ...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 11, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today, at the 2024 International Society of Heart and Lung Transplantation meeting in Prague, Czech Republic, the results from XVIVO's clinical trial, NIHP2019, in heart transplantation were pres...
GOTHENBURG, SWEDEN / ACCESSWIRE / April 4, 2024 / XVIVO Perfusion AB (STO:XVIVO)(LSE:0RKL)(FRA:3XV) Today XVIVO Perfusion AB (publ) publish the Annual Report for 2023. The Annual Report is attached to this press release in pdf format and in ESEF format (European Single Electronic Format) and is...